Unani formulation for Chronic Eczema

Efficacy of Majoon Shahatra and Marham Kafoor in Nar-e-Farsi Muzmin (Chronic Eczema) â?? An Open Labelled Single Arm Clinical Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030759

Enrollment

Registered

2021-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: MAJOON SHAHATRA MARHAM KAFOOR: MAJOON SHAHATRA - 12 g orally twice a day with plain water MARHAM KAFOOR - Local application on affected area daily twice a day Control Intervention1: NI

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WHO WILL GIVE CONSENT AND ABLE TO DO FOLLOW UP

Exclusion criteria

Exclusion criteria: 1.Patients below 18 and above 60 years of age. 2.Pregnant and lactating women. 3.Patients having local wound and other skin diseases. 4.Patients suffering from systemic illnesses like Diabetes Mellitus, Malignancy 5.Patients of Acute Eczema of 2 weeks with vesicles and oozing, Seborrhoeic Dermatitis, Stasis Dermatitis, Psoriasis and Exfoliative Dermatitis.

Design outcomes

Primary

Measure	Time frame
Improvement in objective parameters 1.Eczema Area and Severity Index (EASI) score 2.Patient-oriented Eczema Measure (POEM) Questionnaire 3.Visual Analogue Scale (VAS) for Itching 4.Photographs of the lesionsTimepoint: PRE AND POST TRIAL TOTAL STUDY DURATION IS 40 DAYS	—

Secondary

Measure	Time frame
Improvement in Quality of Life by using Dermatology Life Quality Index (DLQI)Timepoint: 40 DAYS	—

Countries

India

Contacts

Public ContactSABA KHANUM

NATIONAL INSTITUTE OF UNANI MEDICINE

dr.rumman190@gmail.com9450090387

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026